Patent Assignment
Reel/Frame 063165/0455
Assignee Address Correction
Recorded: 2023-03-27
Pages: 10
Assignor
WYETH LLC
Executed: 2023-03-07
Assignee
WYETH LLC
66 HUDSON BOULEVARD EAST, LEGAL PATENT DEPT, CHIEF IP COUNSEL, NEW YORK, NEW YORK, 10001-2192
Covered Properties
(108)
2-Phenyl-1-[4-(2-Aminoethoxy)-Benzyl]-Indole and Estrogen Formulations
Patent:
6,479,535 →
Application:
09/306,073 →
Parenteral Cci-779 Formulations Containing Cosolvents, an Antioxidant, and a Surfactant
Derivatives of Venlafaxine and Methods of Preparing and Using the Same
Removal of High Molecular Weight Aggregates Using Hydroxyapatite Chromatography
4-Anilino-3-Quinolinecarbonitriles for the Treatment of Chronic Myelogenous Leukemia (Cml)
Crystalline Polymorph of Bazedoxifene Acetate
Stabilizing formulations
Systems and Methods for Protein Production
Method of Weak Partitioning Chromatography
Tigecycline Compositions and Methods of Preparation
Separation of Contaminants from Streptococcus Pneumoniae Polysaccharide by Ph Manipulation
Crystalline Solid Forms of Tigecycline and Methods of Preparing Same
Crystalline Forms of 4-[(2,4-Dichloro-5-Methoxyphenyl)Amino]-6-Methoxy-7-[3-(4-Methyl-1-Piperazinyl)Propoxy]-3-Quinolinecarbonitrile and Methods of Preparing the Same
Bazedoxifene Acetate Formulations
Separation Methods
Synergistic Attenuation of Vesicular Stomatitis Virus, Vectors Thereof and Immunogenic Compositions Thereof
Multivalent Pneumococcal Polysaccharide-Protein Conjugate Composition
Multivalent Pneumococcal Polysaccharide-Protein Conjugate Composition
Novel Formulations Which Stabilize and Inhibit Precipitation of Immunogenic Compositions
Pneumococcal Dosing Regimen
Patent:
8,808,707 →
Application:
11/740,580 →
Purification Processes for Isolating Purified Vesicular Stomatitis Virus from Cell Culture
Substituted 3-Cyanopyridines as Protein Kinase Inhibitors
Production of Glycoproteins
High-Cell Density Fed-Batch Fermentation Process for Producing Recombinant Protein
6-Substituted 2-(Benzimidazolyl)Purine and Purinone Derivatives for Immunosuppression
Methods for the Separation of Streptococcus Pneumoniae Type 3 Polysaccharides
Arginine Derivative Wash in Protein Purification Using Affinity Chromatography
Arginine Wash in Protein Purification Using Affinity Chromatography
Glycolysis-Inhibiting Substances in Cell Culture
Rationally Designed Media for Cell Culture
Novel Immunogenic Compositions for the Prevention and Treatment of Meningococcal Disease
Use of Copper and Glutamate in Cell Culture for Production of Polypeptides
Shortened Purification Process for the Production of Capsular Streptococcus Pneumoniae Polysaccharides
Anti-Tumor Activity of Cci-779 in Papillary Renal Cell Cancer
Use of Low Temperature and/or Low Ph in Cell Culture
Treatment of Imatinib Resistant Leukemia
4-Anilino-3-Quinolinecarbonitriles for the Treatment of Chronic Myelogenous Leukemia (Cml)
Process for Producing Aluminum Phosphate
6-Substituted 2-(Benzimidazolyl)Purine and Purinone Derivatives for Immunosuppression
Multivalent Pneumococcal Polysaccharide-Protein Conjugate Composition
Methods of Preparing Polymorphic Form a of Bazedoxifene Acetate
Systems and Methods for Protein Production
Methods for Enhanced Production of Bone Morphogenetic Proteins
Lyophilization Above Collapse
Compatible Display Vector Systems
Purification of Acidic Proteins Using Ceramic Hydroxyapatite Chromatography
Method for Controlling Streptococcus Pneumoniae Serotype 19A Polysaccharide Molecular Weight
Multivalent Pneumococcal Polysaccharide-Protein Conjugate Composition
Crystalline Forms of 4-[(2,4-Dichloro-5-Methoxyphenyl)Amino]-6-Methoxy-7-[3-(4-Methyl-1-Piperazinyl)Propoxy]-3-Quinolinecarbonitrile and Methods of Preparing the Same
Polymorphic Form D of Bazedoxifene Acetate and Methods of Preparing Same
Multivalent Pneumococcal Polysaccharide-Protein Conjugate Composition
Immunogenic Compositions for Inducing an Immune Response to Hiv
Tigecycline Compositions and Methods of Preparation
Membrane Evaporation for Generating Highly Concentrated Protein Therapeutics
Non-Lipidated Variants of Neisseria Meningitidis ORF2086 Antigens
Method of Weak Partitioning Chromatography
Immunogenic Compositions of Staphylococcus Aureus Antigens
Compositions and Methods for Preparing Staphylococcus Aureus Serotype 5 and 8 Capsular Polysaccharide Conjugate Immunogenic Compositions
Multivalent Pneumococcal Polysaccharide-Protein Conjugate Composition
Compositions Relating to a Mutant Clostridium Difficile Toxin and Methods Thereof
Methods of Preparing Polymorphic Form a of Bazedoxifene Acetate
Synergistic Attenuation of Vesicular Stomatitis Virus, Vectors Thereof and Immunogenic Compositions Thereof
Novel Formulations Which Stabilize and Inhibit Precipitation of Immunogenic Compositions
Compatible Display Vector Systems
Vaccine Formulations
Removal Of High Molecular Weight Aggregates Using Hydroxyapatite Chromatography
Stable Formulations of Neisseria Meningitidis RLP2086 Antigens
Compositions Relating to a Mutant Clostridium Difficile Toxin and Methods Thereof
Compositions Relating to a Mutant Clostridium Difficile Toxin and Methods Thereof
Immunogenic Compositions of Staphylococcus Aureus Antigens
High-Cell Density Fed-Batch Fermentation Process for Producing Recombinant Protein
Shortened Purification Process for the Production of Capsular Streptococcus Pneumoniae Polysaccharides
Multivalent Pneumococcal Polysaccharide-Protein Conjugate Composition
Pneumococcal Dosing Regimen
Immunogenic Compositions of Staphylococcus Aureus Antigens
Multivalent Pneumococcal Polysaccharide-Protein Conjugate Composition
Compositions Relating to a Mutant Clostridium Difficile Toxin and Methods Thereof
Tigecycline Compositions and Methods of Preparation
Shortened Purification Process for the Production of Capsular Streptococcus Pneumoniae Polysaccharides
Multivalent Pneumococcal Polysaccharide-Protein Conjugate Composition
Compositions Relating to a Mutant Clostridium Difficile Toxin and Methods Thereof
Compositions and Methods for Preparing Staphylococcus Aureus Serotype 5 and 8 Capsular Polysaccharide Conjugate Immunogenic Compositions
Compositions Relating to a Mutant Clostridium Difficile Toxin and Methods Thereof
Patent:
46,376 →
Application:
14/883,000 →
Tigecycline Compositions and Methods of Preparation
High-Cell Density Fed-Batch Fermentation Process for Producing Recombinant Protein
Process for Preparing Pneumococcal Polysaccharide-Protein Conjugates
Compositions Relating to a Mutant Clostridium Difficile Toxin and Methods Thereof
Patent:
46,518 →
Application:
15/366,702 →
Non-Lipidated Variants of Neisseria Meningitidis ORF2086 Antigens
Pneumococcal Dosing Regimen
Tigecycline Compositions and Methods of Preparation
Compositions Relating to a Mutant Clostridium Difficile Toxin and Methods Thereof
Multivalent Pneumococcal Polysaccharide-Protein Conjugate Composition
Process for Preparing Pneumococcal Polysaccharide-Protein Conjugates
Compositions Relating to a Mutant Clostridium Difficile Toxin and Methods Thereof
Compositions Relating to a Mutant Clostridium Difficile Toxin and Methods Thereof
Patent:
48,862 →
Application:
16/387,999 →
Compositions Relating to a Mutant Clostridium Difficile Toxin and Methods Thereof
Patent:
48,863 →
Application:
16/388,011 →
Pneumococcal Dosing Regimen
Process for Preparing Pneumococcal Polysaccharide-Protein Conjugates
Non-Lipidated Variants of Neisseria Meningitidis ORF2086 Antigens
Compositions Relating to a Mutant Clostridium Difficile Toxin and Methods Thereof
Sodium Chloride Solution for Drug Reconstitution or Dilution
Application:
16/723,563 →
Publication:
US 2020/0138952
Process for Preparing Pneumococcal Polysaccharide-Protein Conjugates
Use Of Perfusion To Enhance Production Of Fed-batch Cell Culture In Bioreactors
Application:
16/907,799 →
Publication:
US 2020/0325441
Method for Controlling Streptococcus Pneumoniae Polysaccharide Molecular Weight Using Carbon Dioxide
Sodium Chloride Solution for Drug Reconstitution or Dilution
Application:
16/946,998 →
Publication:
US 2020/0338199
Process for Preparing Pneumococcal Polysaccharide-Protein Conjugates
Application:
17/328,657 →
Publication:
US 2021/0283247
Pneumococcal Dosing Regimen
Compositions Relating to a Mutant Clostridium Difficile Toxin and Methods Thereof
Application:
18/066,591 →
Publication:
US 2023/0391835
Related Assignments
(12)
Other recorded transfers of the patents in this record — the chain of ownership.
Change of Name
Nov 30, 2011
From: WYETH
To: WYETH LLC
Reel/Frame 027301/0507 →
Change of Address
Nov 3, 2014
From: WYETH LLC
To: WYETH LLC
Reel/Frame 034142/0472 →
Change of Address
Nov 3, 2014
From: WYETH LLC
To: WYETH LLC
Reel/Frame 034143/0211 →
Change of Name
Nov 3, 2014
From: WYETH
To: WYETH LLC
Reel/Frame 034143/0164 →
Change of Address for Assignee
Aug 16, 2016
From: WYETH LLC
To: WYETH LLC
Reel/Frame 039743/0965 →
Articles of Organization-Conversion
Aug 17, 2016
From: WYETH
To: WYETH LLC
Reel/Frame 039709/0843 →
Assignee Address Correction
Aug 23, 2016
From: WYETH LLC
To: WYETH LLC
Reel/Frame 039784/0973 →
Assignee Address Correction
Aug 23, 2016
From: WYETH LLC
To: WYETH LLC
Reel/Frame 039785/0035 →
Assignee Address Correction
Oct 12, 2016
From: SEPRACOR INC.
To: WYETH LLC
Reel/Frame 040332/0964 →
Articles of Organization-Conveyance
Mar 22, 2017
From: WYETH
To: WYETH LLC
Reel/Frame 042067/0896 →
Assignee Name and Address Correction
Aug 7, 2017
From: WYETH
To: WYETH LLC
Reel/Frame 043218/0328 →
Assignee Address Correction
Sep 15, 2017
From: WYETH LLC
To: WYETH LLC
Reel/Frame 043969/0813 →